Home / Inspections / 1214469

FDA Inspection 1214469 — Genesis Fertility & Reproductive Medicine

Genesis Fertility & Reproductive Medicine — FEI 3003972326

The FDA completed an inspection of Genesis Fertility & Reproductive Medicine on August 4, 2023 in Brooklyn, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 4, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Brooklyn, NY (United States)

Facility

Other inspections at this facility

  • 1301302 (NAI Tue Jan 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1112313 (NAI Wed Oct 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1075190 (VAI Fri Dec 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 992579 (NAI Fri Nov 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903598 (VAI Thu Nov 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources